Surveillance imaging of grade 1 astrocytomas in children: can duration and frequency of follow-up imaging and the use of contrast agents be reduced?

Autor: Campion T; Radiology Department, Great Ormond Street Hospital, London, UK. thomascampion@nhs.net., Quirk B; Radiology Department, Great Ormond Street Hospital, London, UK., Cooper J; Radiology Department, Great Ormond Street Hospital, London, UK., Phipps K; Neurosurgery Department, Great Ormond Street Hospital, London, UK., Toescu S; Developmental Neurosciences Department, Institute of Child Health, University College London, London, UK., Aquilina K; Neurosurgery Department, Great Ormond Street Hospital, London, UK., Green K; Haematology and Oncology Department, Great Ormond Street Hospital, London, UK., Hargrave D; Haematology and Oncology Department, Great Ormond Street Hospital, London, UK., Mankad K; Radiology Department, Great Ormond Street Hospital, London, UK.
Jazyk: angličtina
Zdroj: Neuroradiology [Neuroradiology] 2021 Jun; Vol. 63 (6), pp. 953-958. Date of Electronic Publication: 2020 Nov 25.
DOI: 10.1007/s00234-020-02609-3
Abstrakt: Purpose: The optimum strategy for the surveillance of low-grade gliomas in children has not been established, and there is concern about the use of gadolinium-based contrast agents (GBCAs), particularly in children, due to their deposition in the brain. The number of surveillance scans and the use of GBCAs in surveillance of low-risk tumours should ideally be limited. We aimed to investigate the consistency and utility of our surveillance imaging and also determine to what extent the use of GBCAs contributed to decisions to escalate treatment in children with grade 1 astrocytomas.
Methods: This was a retrospective single-centre study at a tertiary paediatric hospital. All children with a new diagnosis of a non-syndromic World Health Organization (WHO) grade 1 astrocytoma between 2007 and 2013 were included, with surveillance imaging up to December 2018 included in analysis. The intervals of surveillance imaging were recorded, and imaging and electronic health records were examined for decisions related to treatment escalation.
Results: Eighty-eight patients had 690 surveillance scans in the study period. Thirty-one patients had recurrence or progression leading to treatment escalation, 30 of whom were identified on surveillance imaging. The use of GBCAs did not appear to contribute to multidisciplinary team (MDT) decisions in the majority of cases.
Conclusion: Surveillance imaging could be reduced in number and duration for completely resected cerebellar tumours. MDT decisions were rarely made on the basis of post-contrast imaging, and GBCA administration could therefore potentially be restricted in the setting of surveillance of grade 1 astrocytomas in children.
Databáze: MEDLINE
Externí odkaz: